Literature DB >> 30007944

Hypoventilation disproportionate to OSAS severity in children with Prader-Willi syndrome.

Francois Abel1, Hui-Leng Tan2, Valentina Negro2, Nicola Bridges3, Thomas Carlisle2, Elaine Chan1, Aidan Laverty1, Michael Miligkos4,5, Martin Samuels1, Athanasios G Kaditis4.   

Abstract

OBJECTIVE: To test the hypothesis that children with Prader-Willi syndrome (PWS) and obstructive sleep apnoea syndrome (OSAS) have hypercapnia for higher proportion of total sleep time (TST) than non-syndromic children with similar obstructive apnoea-hypopnoea index (OAHI).
DESIGN: Cross-sectional study.
SETTING: Two tertiary care hospitals. PATIENTS: Patients with PWS and non-syndromic children with snoring who underwent polygraphy and were of similar age, body mass index (BMI) z-score and OAHI. MAIN OUTCOME MEASURE: The two groups were compared regarding %TST with transcutaneous CO2 (PtcCO2) >50 mm Hg. The interaction between PWS diagnosis and OSAS severity (OAHI <1 episode/h vs 1-5 episodes/h vs >5 episodes/h) regarding %TST with PtcCO2 >50 mm Hg was tested using multiple linear regression.
RESULTS: 48 children with PWS and 92 controls were included (median age 2.3 (range 0.2-14.1) years vs 2.2 (0.3-15.1) years; BMI z-score 0.7±1.9 vs 0.8±1.7; median OAHI 0.5 (0-29.5) episodes/h vs 0.5 (0-33.9) episodes/h; p>0.05). The two groups did not differ in %TST with PtcCO2 >50 mm Hg (median 0% (0-100%) vs 0% (0-81.3%), respectively; p>0.05). However, the interaction between PWS and OSAS severity with respect to duration of hypoventilation was significant (p<0.01); the estimated mean differences of %TST with PtcCO2 >50 mm Hg between children with PWS and controls for OAHI <1 episode/h, 1-5 episodes/h and >5 episodes/h were +0.2%, +1% and +33%, respectively.
CONCLUSION: Increasing severity of upper airway obstruction during sleep in children with PWS is accompanied by disproportionately longer periods of hypoventilation when compared with non-syndromic children with similar frequency of obstructive events. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  respiratory; sleep

Mesh:

Substances:

Year:  2018        PMID: 30007944     DOI: 10.1136/archdischild-2017-314282

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Patients with Prader-Willi Syndrome (PWS) Underwent Bariatric Surgery Benefit more from High-Intensity Home Care.

Authors:  Songhao Hu; Biao Huang; Ken Loi; Xiaomei Chen; Qinyu Ding; Lan Luo; Cunchuan Wang; Wah Yang
Journal:  Obes Surg       Date:  2022-03-15       Impact factor: 3.479

Review 2.  Diagnosis and management of sleep disorders in Prader-Willi syndrome.

Authors:  Jessica Duis; Lara C Pullen; Maria Picone; Norman Friedman; Stephen Hawkins; Elise Sannar; Anna C Pfalzer; Althea Robinson Shelton; Deepan Singh; Phyllis C Zee; Daniel G Glaze; Amee Revana
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

3.  Sleep-disordered breathing in school-aged children with Prader-Willi syndrome.

Authors:  Jennifer Schaefer; Margot J Davey; Gillian M Nixon
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

Review 4.  Requirements for improving health and well-being of children with Prader-Willi syndrome and their families.

Authors:  Jessica Mackay; Zoe McCallum; Geoffrey R Ambler; Komal Vora; Gillian Nixon; Philip Bergman; Nora Shields; Kate Milner; Nitin Kapur; Patricia Crock; Daan Caudri; Jaqueline Curran; Charles Verge; Chris Seton; Andrew Tai; Elaine Tham; Yassmin Musthaffa; Antony R Lafferty; Greg Blecher; Jessica Harper; Cara Schofield; Aleisha Nielsen; Andrew Wilson; Helen Leonard; Catherine S Choong; Jenny Downs
Journal:  J Paediatr Child Health       Date:  2019-06-30       Impact factor: 1.954

5.  Sleep Challenges in Children with Prader-Willi Syndrome: A Patient and Family Handout.

Authors:  David G Ingram; Jill M Arganbright; Kelsee L Halpin; Caroline Okorie
Journal:  ATS Sch       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.